Article found in – HAART and correlated pathologies n. 26 – Download the article
Evaluating HIV/AIDS education and prevention models targeting minorities, mobile and migrant populations: A systematic literature review
ABSTRACT The 2008-2011 aids&mobility project aimed to improve health literacy and awareness among the immigrant population of HIV and the health service availability by training young migrants as certified transcultural mediators to promote health and prevention in their communities. The project established its […]
Management of invasive fungal Infections in non-neutropenic patients
ABSTRACT Invasive fungal infections (IFIs) are documented in critically ill, non-neutropenic patients, in intensive care units (ICUs) and surgical wards, but also in non critical patients cared for in medical wards. Candida spp. infections mainly occur in patients undergone to major abdominal surgery, […]
HIV regimens de-intensification with PI monotherapy: one size does not fit all
ABSTRACT The 2008-2011 aids&mobility project aimed to improve health literacy and awareness among the immigrant population of HIV and the health service availability by training young migrants as certified transcultural mediators to promote health and prevention in their communities. The project established its […]
Editorial
It is hard to define: if is reality that suggests stories and characters, or if stories could be used to understand realities. As it often happens, the relation is complex to be analized. In some way we could assume a similar approach that […]
Thucydides, HIV and HCV. About the contemporary
It could be an unusual mix to put together the greatest Athenian historian, a 30 years old pandemic and hepatitis (mainly HCV infection). But if you have 5 minutes of your time to waste, follow my joke. Because a conceptual link could be […]
DAAs: the lexicon of a changing paradigm – Interview with Heiner Wedemeyer
“When we will have the new HCV drugs which are in development, when they will came to market, it will be on us –clinicians, scientists together with the patients- to further optimize also these new tools- tell to me with emphasis Heiner Wedemeyer, […]
Switching mentality: how “COME” could suggest the way – Interview with Stefano Fagiuoli
During the last EASL meeting, probably it was the study with the highest number of citation, because it was able to define the burden of HCV infection in our world, let’s say in real life. Supported by EpaC – the Italian hepatitis patient […]
Hepatitis and stakeholders in Europe – Interview with Markus Peck-Radosavljevic
“We are considering the stakeholders that are involved in the management of the clinical condition of hepatitis”: well said Markus Peck-Radosavljevic, Associate Professor of Medicine at the Department of Gastroenterology and Hepatology at the Medizinische Universität Wien, Austria, in the speech he gave […]
The future and the present of DAAs against HCV – Interview with Mark Thurz
So, my name is Mark Thursz and I am the Secretary General of the European Association for the Study of the Liver and we are here now at the 47th International Liver Congress in Barcelona and one of the most exciting things that […]
